Navigation Links
Cedars-Sinai to hold first annual conference on stem cell therapies for neurological disorders
Date:4/28/2011

LOS ANGELES (April 28, 2011) Experts from stem cell programs at respected research centers around the country will present information at an April 30 conference on stem cell therapy for neurological disorders, hosted by the Department of Neurosurgery at Cedars-Sinai Medical Center in collaboration with the Genetics Policy Institute of Wellington, Fla.

Topics include stem cell therapies for:

  • brain tumors;
  • stroke;
  • neurodegenerative disorders,
  • spinal cord injury; and
  • spinal disorders.
  • The final session of the conference will address the future of stem cell therapies.

Guest faculty will include:

  • Karen S. Aboody, MD, associate professor, Department of Neurosciences and Division of Neurosurgery, City of Hope National Medical Center and Beckman Research Institute, Duarte, CA

  • Nicholas Boulis, MD, associate professor, Department of Neurosurgery, Emory University, Atlanta, GA

  • Michael Chopp, MD, scientific director, Neuroscience Institute; vice chairman, Department of Neurology; Zoltan J. Kovacs Chair in Neuroscience Research; Henry Ford Hospital Distinguished Professor of Physics, Oakland University, Detroit, MI

  • Hans Keirstead, PhD, associate professor of Anatomy and Neurobiology; associate professor of Neurological Surgery, University of California School of Medicine, Irvine, CA

  • Robert Klein, JD, California Institute for Regenerative Medicine Governing Board, San Francisco, CA

  • Jeremy N. Rich, MD, chairman, Department of Stem Cell Biology and Regenerative Medicine, Lerner Research Institute, Cleveland Clinic, Cleveland, OH

  • Bernard Siegel, JD, executive director of Genetics Policy Institute, Wellington, FL

  • Evan Y. Snyder, MD, PhD, professor, Sanford-Burnham Medical Research Institute; director, Program in Stem Cell and Regenerative Biology; director, Stem Cell Research Center, San Diego, CA

  • Gary K. Steinberg, MD, PhD, Bernard and Ronni Lacroute-William Randolph Hearst Professor of Neurosurgery and the Neurosciences; chairman, Department of Neurosurgery; director, Stanford Institute for Neuro-Innovation and Translational Neurosciences, Stanford University School of Medicine, Stanford, CA

  • Edward Wirth III, MD, PhD, medical director, Regenerative Medicine, Geron Corporation, Menlo Park, CA

Course directors will be:

  • John S. Yu, MD, professor and vice chairman, Department of Neurosurgery; director, Brain Tumor Center of Excellence; director, Surgical Neuro-Oncology; neurosurgical director, Gamma Knife Center, Cedars-Sinai Medical Center

  • Keith L. Black, MD, professor and chairman, Department of Neurosurgery; director, Maxine Dunitz Neurosurgical Institute; director, Johnnie L. Cochran, Jr. Brain Tumor Center; Ruth and Lawrence Harvey Chair in Neuroscience, Cedars-Sinai Medical Center

Co-directors will be:

  • J. Patrick Johnson, MD, co-director, Spine Stem Cell Research Program, Cedars-Sinai Spine Center

  • Patrick D. Lyden, MD, chairman, Department of Neurology; Carmen and Louis Warschaw Chair in Neurology, Cedars-Sinai Medical Center

  • Clive Svendsen, PhD, director, Regenerative Medicine Institute, Department of Biomedical Sciences, Cedars-Sinai Medical Center

The conference, "Stem Cell Therapies for Neurological Disorders: Current Challenges to Clinical Translation," will run from 7:30 a.m. to 3:30 p.m. in Cedars-Sinai's Harvey Morse Auditorium, Plaza Level, South Tower, 8700 Beverly Blvd. It is not open to the public.


'/>"/>

Contact: Sandy Van
sandy@prpacific.com
808-526-1708
Cedars-Sinai Medical Center
Source:Eurekalert

Related medicine news :

1. Cedars-Sinais mobile medical clinics receive grant from George Hoag Family Foundation
2. Cedars-Sinai research team awarded $1.9 million from CIRM to develop new tools and technologies
3. Cedars-Sinai Medical Genetics Institute director honored with lifetime achievement award
4. Cedars-Sinai nano-drug hits brain-tumor target found in 2001
5. Cedars-Sinai awarded $1.9 million from CIRM to develop stem cell treatments for osteoporosis
6. Cedars-Sinai Pathology and Laboratory Medicine chair recognized with 2 of the fields top honors
7. Adults demonstrate modified immune response after receiving massage, Cedars-Sinai researchers show
8. Bigge Building Cedars-Sinai New West Tower
9. Cedars-Sinai heart transplantation tip sheet
10. Cedars-Sinai Medical Center Names Beverly Hills Plastic Surgeon Dr. Andrew Cohen as Chief of the Center for Plastic and Reconstructive Surgery
11. Cedars-Sinai study examines regional use of minimally invasive repair of aneurysms
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/26/2017)... ... July 26, 2017 , ... ... cats has opened in Jupiter. The state of the art center will ... leading treatments with a goal of providing heart patients longer lives. , North ...
(Date:7/26/2017)... FL (PRWEB) , ... July 26, 2017 , ... ... nation’s leading innovative specialty pharmacies, has released an updated version of the HCV ... latest guidelines for treating chronic hepatitis C virus (HCV) infection. All of the ...
(Date:7/25/2017)... MOORE, OK (PRWEB) , ... July 25, 2017 ... ... are proud to announce the launch of their partnership to provide the ... is the first pharmacy-focused platform in the country with the ability to develop ...
(Date:7/25/2017)... ... July 25, 2017 , ... Dr. Gina ... Negrette has more than a decade of experience in psychiatry, treating clients in ... fighting addictions, eating disorders, psychotic and manic conditions, as well as those who ...
(Date:7/24/2017)... ... July 24, 2017 , ... Contact: ... Robins & Morton, Perkins Will, Newcomb & Boyd, Walter P Moore and ... new Destination Medical Building located at Mayo Clinic in Jacksonville, Florida. , ...
Breaking Medicine News(10 mins):
(Date:7/20/2017)... Minn. , July 20, 2017  Prime Therapeutics LLC ... Jonathan Gavras , M.D., following today,s Institute for Clinical and ... report on the effectiveness and value of abuse-deterrent formulations ... on the policy roundtable at the meeting. ... not a material cost benefit to the use of abuse-deterrent ...
(Date:7/14/2017)... -- It should come as no surprise to anyone that ... midst of a crippling opioid epidemic. According to the ... overdose deaths from opiate-based medications has quadrupled, Says, Dr. ... from 2001 to 2015". During this time, the prescription rate ... drawing a compelling link between prescription and eventual addiction. The ...
(Date:7/12/2017)... and Company (NYSE: LLY ) has entered into ... litigation in the U.S. District Court for the Eastern District ... (tadalafil) unit dose patent. This patent was previously set ... agreement, Cialis exclusivity is now expected to end at the ... patent for Cialis is valid and infringed by companies seeking ...
Breaking Medicine Technology: